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Introduction: Two principal findings of cardiovascular disease in end-stage renal disease 
patients undergoing regular hemodialysis are left ventricular hypertrophy (LVH) and arterial 
disease due to rapidly progressive atherosclerotic vascular disease that can be characterized by 
an enlargement and hypertrophy of arteries (intima-media complex thickening; IMT).
Objectives: In this study, we sought to evaluate the relationship between left ventricular 
hypertrophy with intima-media complex thickening in end-stage renal disease patients undergoing 
regular hemodialysis.
Patients and Methods: Sixty-one patients with end-stage renal disease (ESRD) who were 
undergoing regular and maintenance hemodialysis treatment (F=23, M=38) were studied. 
The subjects consisted of 50 non-diabetic hemodialysis patients (F=20, M=30) and 11 diabetic 
hemodialysis patients (F=3, M=8). For all the subjects, echocardiography and carotid intima-
media thickness measuring by B-mode ultrasonography were performed.
Results: In this study, there was a positive correlation between stages of LVH with duration 
of hemodialysis treatment, stages of hypertension (HTN), and with carotid-IMT. A positive 
correlation was also seen between stages of LVH and presence of chest pain, and more thickening 
of the intima-media complex was seen in the diabetic group. Diabetes mellitus was associated 
with the presence of chest pain, as was positive correlation between stages of HTN with IMT, and 
a reverse correlation was observed between IMT with the percent of cardiac ejection fraction.
Conclusion: Prevalence of thickening in intima-media complex is more evident in hemodialysis 
subjects with LVH. When there is LVH, IMT is similar in severity to the LVH.
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Prevalence of thickening in intima-media complex is more evident in hemodialysis subjects with left ventricular hypertrophy. When 
there is left ventricular hypertrophy, intima-media complex thickening is similar in severity to the left ventricular hypertrophy.
Please cite this paper as: Rafieian-Kopaei M, Nasri H. Carotid intima-media thickness and left ventricular hypertrophy in hemodialysis patients. J Renal Inj Prev 2013; 2(4): 129-132. DOI: 10.12861/jrip.2013.42
*Corresponding author: Prof. Hamid Nasri, Department of Internal Medicine, Shahrekord University of Medical Sciences, 
Shahrekord, Iran. E-mail: hamidnasri@yahoo.com
Introduction   
Cardiovascular disease is the principal cause of morbidity and 
mortality in hemodialysis (HD) patients (1-2). The principal 
findings of cardiovascular disease are left ventricular 
hypertrophy (LVH), as determined by echocardiography (2,3), and arterial disease due to rapidly progressive 
atherosclerotic vascular disease (2-4), characterized by an 
enlargement and hypertrophy of arteries  [intima-media 
complex thickening (IMT)] as can be determined by B-mode 
ultrasonography (2-4). LV mass increases progressively as 
renal function deteriorates and is exceedingly frequent in 
patients undergoing dialysis (1-3). Indeed, LVH and arterial 
disease are the two principal risk factors for cardiovascular mortality in hemodialysis patients (2-5). Carotid-IMT (c-IMT) is a marker of early atherosclerosis, its anatomic 
extent and progression, and IMT is increased in subjects 
with several risk factors and is a predictor of cardiovascular 
events and end-organ damage (6). Clinical manifestations 
of cardiovascular disease often arise in a stage of well-advanced atherosclerosis (6,7). However, arterial vessel 
wall changes occur during a presumably long sub-clinical 
lag phase characterized by functional disturbances and 
by gradual thickening of intima-media (6,7). IMT of large 
peripheral arteries, especially the carotid, can be assessed 
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by B-mode ultrasound in a relatively simple way (6-8), thus 
the measurement of IMT has emerged as one of the methods 
of choice for determining early atherosclerotic changes, 
the anatomic extent of atherosclerosis and its progression 
and showing the effectiveness of medical therapy (6-8). 
Therefore, considerable attention has been directed toward 
cIMT by B-mode ultrasound, which can directly assess 
the IMT, corresponding to the thickness of the histologic intima and media (6-9). Bodies of evidence have shown that 
cIMT is a strong predictor of cardiovascular disease in the 
general population (6-8). However, the question remains as 
to whether ultrasonographic studies of cIMT are useful to 
find any relationship between with end-stage renal disease-
related (ESRD-related) vascular changes as cIMT with LVH 
in HD patients (6-9). The cardiovascular mortality rate is 
elevated in those ESRD, diabetes mellitus and especially in 
those with diabetes mellitus and ESRD (1-4,6-9). 
Objectives
We studied a group of hemodialysis patients consisting of 
diabetics and non-diabetics to find an association between 
IMT with LVH and IMT with severity of hypertension and chest pain.
Patients and Methods
Patients
This cross-sectional study was done on 61 unselected 
patients ESRD, undergoing regular HD. Patient exclusion 
criteria were cigarette smoking, body mass index (BMI) 
more than 25, anti-lipid drug use, recent MI and vascular 
diseases as well as pericarditis and pericardial effusion 
in echocardiography. For stratification of hypertensive 
patients, according to the sixth and seventh report of 
the Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of High Blood Pressure, we 
stratified hypertensive patients from stage one to three 
(stage zero equal to no HTN) (10). Stages of hypertension 
of HD patients were considered before treatment and at the start of hemodialysis treatment (10). 
Assessment of intima-media complex thickening
Carotid sonography was done by a single sonologist 
unaware of history or lab data of patients with a Honda-
HS-2000 Sonograph and 7.5 MHz linear probe to measure IMT (4,8). The procedure was done at the end of diastolic 
phase; the sites of measurements were at the distal common 
carotid artery, area of bifurcation and at the proximal internal carotid artery (4,8). IMT was measured at the 
plaque-free areas with subjects in the supine position with 
neck hyperextension and head rotation for facilitation of the 
procedure. The carotids were evaluated in the longitudinal 
axis. By sonography, the carotid artery was found to have 
three different echoes: intima, as an echogenic layer line; 
media, as a hypoecho-layer; and an echogenic adventitia. 
IMT was defined as the distance from the leading edge of 
lumen-intima interface of the far wall to the leading edge of the media adventitia interface of the far wall. IMT more than 
0.8 mm was considered abnormal (4,8) . A single cardiologist 
unaware of the patients’ data performed all the echo-
cardiographies to determine left ventricular hypertrophy. 
On the basis of sepal thickness, we stratified the patients to 
no LVH (septal thickness between 6-11 mm), mild (septal 
thickness between 11-15 mm), moderate (septal thickness 
between 15-18 mm) and severe LVH (septal thickness>18 
mm). LVH measurements were done at the end-diastolic phase (1-4,8). Cardiac ejection fraction between 55 to 75% was considered normal (1-4). We measured the mean right and left carotid IMT. 
Ethical issuesThe research followed the tenets of the Declaration of 
Helsinki; written informed consent was obtained; and the 
research was approved by ethical committee of Shahrekord University of Medical Sciences.
Statistical analysis
For statistical analysis, descriptive data are expressed as 
Mean±SD. Comparison between groups was performed 
using chi-squared test, Mann-Whitney U, as well as Kruskal-
Wallis and Fisher’s exact test. For correlations, we used 
Spearman’s rho, Phi and Cramer’s V and also Eta tests. In 
addition, partial correlation test (with adjustment for age) 
was used. All statistical analysis was performed using SPSS 
version 11.00. Statistical significance was inferred at a p< 
0.05.
ResultsThe total number of patients was 61 (F=23, M=38), which consisted of 50 non-diabetic hemodialysis patients 
(F=20, M=30) and 11 diabetic hemodialysis patients (F=3, 
M=8). Table 1 shows the mean±SD of data; Tables 2, 3 and 4 show the frequency distribution of chest pain, stages of 
HTN and stages of LVH in the patients. Mean±SD of the 
age of the subjects was 46.5±16 years. Mean±SD length 
of time, the patients had been on HD was 32±31 months. 
Mean±SD of cardiac ejection fraction was 51±8.9 percent. 
Also 39.3% of the patients had cardiac chest pain. In this 
study, there were no significant differences in age, percent 
of cardiac ejection fraction, cIMT and duration of HD 
between the males and females (p>0.05, Mann-Whitney 
U test). Also, there was no significant difference in LVH 
between the two sexes (chi-square test, p>0.05). There 
was no significant difference in the presence of chest pain 
or DM between the two sexes (Fisher’s exact test, p>0.05). 
No significant difference was found between gender and 
stages of hypertension (chi-square test, p>0.05). In this 
study, there was a positive correlation between stages of 
LVH and duration of HD treatment (p<0.01), However, 
no significant difference between stages of LVH and age 
(p>0.005, Kruskal-Wallis) was found. There was a positive 
relationship between stages of LVH and stages of HTN 
(r=0.580, p<0.001). There was no significant correlation 
between DM and LVH (Phi and Cramer’s V test, p>0.05). We 
found a significant difference between stages of LVH with 
cIMT (Kruskal-Wallis test, p>0.05). We found a significant 
positive correlation between presence of chest pain and DM 
(p<0.001), but no association between the presence of DM 
with presence of HTN, or gender with DM (Phi and Cramer’s 
V test, p>0.005). There was a significant difference of cIMT 
between the diabetic and non-diabetic groups (1.3±0.3 vs. 
1±0.25 mm, respectively, p<0.05, Eta test). No correlation 
was found between DM and ejection fraction (p>0.005, Eta 
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Table 1. Mean±SD, minimum and maximum of data
Age
years
D.H.T*
months
IMT**
mm
EF***
percent
Total 
Patients
n=61
Mean±SD 46.5±16 32±31 1.06±0.3 51±8.9
Min 15 2 0.50 25
Max 78 108 1.70 70
Diabetic
n=11
Mean±SD 57±16 22.6±22 1.3±0.3
Min 27 3 0.80 30
Max 78 60 1.70 55
Non- 
diabetic
N=50
Mean±SD 47.8±16 34±33 1±0.25
Min 15 2 0.50 25
Max 78 108 1.60 70
*duration of HD, **carotid-IMT, *** ejection fraction
Table 2. Frequency distribution of stages of HTN
Stages of 
HTN
Total patients
N=61
DM group*
N=11
Non- DM group
N=50
No. % No. % No. %
0 4 6.6 0 0 4 8
1 5 8.2 0 0 5 10
2 33 54.1 8 72.7 25 50
3 19 31.1 3 27.3 16 32
Table 3. Frequency distribution of chest pain in HD patients
Chest pain
Total patients
N=61
DM group
N=11
Non- DM group
N=50
No. % No. %
Yes 24 39.3 9 81.8
No 34 60.7 2 18.2
Table 4. Frequency distribution of LVH in hemodialysis patients
Total patients
N=61
DM group
N=11
Non- DM group
N=50
No. % No. % No. %
No  LVH 9 14.8 1 9 8 16
Mild  LVH 25 41 4 36.4 21 42
Mod LVH 20 32.8 4 36.4 16 36
Sever LVH 7 11.5 2 18.2 5 10
test), and no significant difference existed between duration 
of hemodialysis, age and ejection fraction between the 
diabetic and non-diabetic groups (p>0.05, Mann-Whitney 
U test). No significant correlation was found between 
ejection fraction and duration of hemodialysis treatment 
(p>0.05, Spearman’s rho). A significant correlation was 
observed between presence of chest pain and stages of LVH 
(p<0.001, Phi and Cramer’s V test). There was no difference 
between stages of HTN with presence of chest pain (p>0.05, 
chi-square test). Statistical analysis on cIMT with partial 
correlation test after adjustment for age showed no positive 
correlation between cIMT with duration of HD (p>0.05), and 
reverse correlation between cIMT with percent of ejection 
fraction (r = -0.353, p=0.005). Also, a positive association 
between cIMT and stages of HTN was observed (r =0.266, 
p=0.020).
Discussion
The principal findings of the present study were a positive 
correlation between stages of LVH with duration of HD, 
positive correlation between LVH with hypertension. Also, 
a positive correlation between stages of LVH with presence 
of chest pain, more thickening of the cIMT in the diabetic 
group was observed. We also found an association of 
diabetes mellitus with the presence of chest pain, a positive 
correlation between stages of HTN with cIMT. Finally, an 
inverse correlation between cIMT with percent of cardiac 
ejection fraction was observed too. Strauman et al. in a study 
on 62 patients on maintenance hemodialysis observed 
65% prevalence of LV hypertrophy and showed that age, 
body mass index and duration of HTN were associated 
with LV hypertrophy and asymmetric septal hypertrophy (11). Greaves et al. in the evaluation of 30 HD patients and 
54 patients under peritoneal dialysis compared with 38 
ESRD patients not yet on dialysis demonstrated that left 
ventricular wall thickness was greater in the dialysis group (12). Nishizawa et al. in a study on 438 patients with ESRD 
treated with hemodialysis showed a significantly greater 
risk for death from cardiovascular causes in patients who 
had significant higher IMT (13). Lin et al. in a research on 
forty normotensive HD patients demonstrated that LV mass 
was significantly positively related to cIMT (14). London et 
al. studied 70 uncomplicated ESRD patients and observed a 
significant correlation of ventricular wall thickness as well 
as left ventricular mass with cIMT (15). Zoccali et al. in an 
evaluation of 254 patients undergoing dialysis concluded 
that LV mass is a strong and independent predictor of 
survival and cardiovascular events in these patients (16). Muiesan et al. in a study to evaluate the structural 
association between the carotid artery and left ventricle 
in a general population in northern Italy showed that the 
common cIMT was significantly greater in subjects with 
concentric left ventricular hypertrophy (17). Our results 
provide the first direct evidence that diabetic patients with 
ESRD undergoing HD had more accelerated atherosclerosis 
and more involvement by ischemic heart disease (IHD) 
than non-diabetic hemodialysis patients. We found the 
association between cIMT and LVH and especially reverse 
correlation between cIMT with cardiac ejection fraction, 
meaning that thickening of the intima-media complex and 
cardiovascular involvement, especially LVH in hemodialysis 
patients, could have an accelerated atherosclerotic base, 
albeit other factors are involved. We have also demonstrated 
that cIMT is related to LVH, although the confirmation of this 
cardio-arterial interaction further highlights the importance 
of structural changes in large arteries in the pathogenesis 
of LVH in HD patients. Mallion believed that the prevalence 
of thickening in intima-media was more evident in subjects 
with LVH and that the presence of concentric remodeling 
of the left ventricle without LVH was associated with an increase in IMT (18). 
Conclusion
When there is LVH-in particular concentric- the IMT is 
similar in severity to the LVH. However, the question 
is whether carotid ultrasonography added relevant 
information to echocardiography-measured LVH in 
hemodialysis patients. Although cIMT has a prediction 
power for cardiovascular death independent of LVH, larger 
studies are needed to allow of better appreciation of the 
relative value of ultrasonography-measured IMT in these 
patients. Prevalence of thickening in intima-media complex 
is more evident in hemodialysis subjects with left ventricular 
hypertrophy. When there is left ventricular hypertrophy, 
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intima-media complex thickening is similar in severity to 
the left ventricular hypertrophy.
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